Applicant, as named in the Orange Book

United Therap

Next listed expiry: Remodulin on 29 Mar 2029. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Remodulin · 5 strengths treprostinil	treprostinil	021272	29 Mar 2029	patent
Orenitram · 5 strengths treprostinil diolamine	treprostinil diolamine	203496	11 Aug 2031	patent
Tyvaso treprostinil	treprostinil	022387	3 Feb 2042	patent, carve-out possible
Tyvaso Dpi · 5 strengths treprostinil	treprostinil	214324	3 Feb 2042	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.